Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 1/2010

01-02-2010 | Research Article

Information sources used by women in Finland who use hormonal contraceptives

Authors: Miia Tiihonen, Anna-Mari Heikkinen, Hanna-Mari Leppänen, Riitta Ahonen

Published in: International Journal of Clinical Pharmacy | Issue 1/2010

Login to get access

Abstract

Objective The aim of this study was to examine information sources used by women who use hormonal contraceptives (HCs), and how information source affected women’s attitudes and perceptions in 2001 and 2007. Setting The questionnaires were distributed from university pharmacies in 12 large cities across Finland. Method The data were collected with two questionnaire surveys among women who used hormonal contraceptives in 2001 and 2007. In the 2001 survey the response rate was 53% (n = 264) and in the 2007 survey 55% (n = 436). Results The number of respondents who considered professional information sources the most important information sources was markedly bigger in 2007 than in 2001 (P = 0.005). The most common source of information concerning the benefits of hormonal contraceptives was a physician (2001: 43%, 2007: 53%). The most common source of information concerning the risks of hormonal contraceptives was friends and relatives (43%) in 2001 and physician in 2007 (35%). Only a few percent of the respondents considered a pharmacy the most important information source both the 2001 and 2007 surveys. Conclusion The importance of health care professionals as sources of information concerning hormonal contraceptives has increased. However, role of pharmacists as information source was surprisingly small. Women who use hormonal contraceptives need more information from professional sources to alleviate possible fears associated with use.
Literature
1.
go back to reference Kosunen EA, Sihvo S, Nikula M, Hemminki E. Birth control. In: Koponen P, Luoto R, editors. Reproductive health in Finland. The Health 2000 survey. B/2004 ed. Helsinki: National Public Health Institute; 2004. ISBN 951-740-422-0. Kosunen EA, Sihvo S, Nikula M, Hemminki E. Birth control. In: Koponen P, Luoto R, editors. Reproductive health in Finland. The Health 2000 survey. B/2004 ed. Helsinki: National Public Health Institute; 2004. ISBN 951-740-422-0.
2.
go back to reference Koponen P, Lindbohm M-L, Sihvo S. Pregnancies, deliveries, miscarriages and abortions. In: Koponen P, Luoto R, editors. Reproductive health in Finland. The Health 2000 survey. B/2004 ed. Helsinki: National Public Health Institute; 2004. ISBN 951-740-422-0. Koponen P, Lindbohm M-L, Sihvo S. Pregnancies, deliveries, miscarriages and abortions. In: Koponen P, Luoto R, editors. Reproductive health in Finland. The Health 2000 survey. B/2004 ed. Helsinki: National Public Health Institute; 2004. ISBN 951-740-422-0.
3.
go back to reference National Agency for medicines and social Insurance Institution. The Finnish Statistics of Medicine 1995–2005. Helsinki: Edita Prima Oy. ISSN 0786-2180. National Agency for medicines and social Insurance Institution. The Finnish Statistics of Medicine 1995–2005. Helsinki: Edita Prima Oy. ISSN 0786-2180.
6.
go back to reference Kontula O, Meriläinen H. In: Finnish: Koulun seksuaalikasvatus 2000-luvun Suomessa. Helsinki: Väestöliitto (The Family Federation); 2007. ISBN 978-951-9450-69-8. Kontula O, Meriläinen H. In: Finnish: Koulun seksuaalikasvatus 2000-luvun Suomessa. Helsinki: Väestöliitto (The Family Federation); 2007. ISBN 978-951-9450-69-8.
7.
go back to reference Jones RK, Darroch JE, Henshaw SK. Contraceptive use among U.S. women having abortions in 2000–2001. Perspect Sex Reprod Health. 2002;34:294–303.CrossRefPubMed Jones RK, Darroch JE, Henshaw SK. Contraceptive use among U.S. women having abortions in 2000–2001. Perspect Sex Reprod Health. 2002;34:294–303.CrossRefPubMed
8.
go back to reference Tiihonen MJ, Leppänen H-M, Heikkinen A-M, Ahonen RS. Hormonal contraceptive users’ self-reported benefits, adverse reactions and fears in 2001 and 2007. Patient. 2008;1:173–80. Tiihonen MJ, Leppänen H-M, Heikkinen A-M, Ahonen RS. Hormonal contraceptive users’ self-reported benefits, adverse reactions and fears in 2001 and 2007. Patient. 2008;1:173–80.
9.
10.
go back to reference Little P, Griffin S, Kelly J, Dickson N, Sadler C. Effect of educational leaflets and questions on knowledge of contraception in women taking the combined contraceptive pill: randomised controlled trial. Br Med J. 1998;316:1948–52. Little P, Griffin S, Kelly J, Dickson N, Sadler C. Effect of educational leaflets and questions on knowledge of contraception in women taking the combined contraceptive pill: randomised controlled trial. Br Med J. 1998;316:1948–52.
11.
go back to reference Vainio KK, Airaksinen MSA, Hyykky TT, Enlund KH. Effect of therapeutic class on counseling in community pharmacies. Ann Pharmacother. 2002;36:781–6.CrossRefPubMed Vainio KK, Airaksinen MSA, Hyykky TT, Enlund KH. Effect of therapeutic class on counseling in community pharmacies. Ann Pharmacother. 2002;36:781–6.CrossRefPubMed
12.
go back to reference Aslanpour Z, Smith FJ. Oral councelling on dispensed medication: a survey of its extent and associated factors in random sample of community pharmacies. Int J Pharm Pract. 1997;5:57–63. Aslanpour Z, Smith FJ. Oral councelling on dispensed medication: a survey of its extent and associated factors in random sample of community pharmacies. Int J Pharm Pract. 1997;5:57–63.
13.
go back to reference Vainio KK, Airaksinen MSA, Väisänen T, Enlund H. Assessing the importance of community pharmacies as providers of drug information. J Appl Ther Res. 2004;5:24–8. Vainio KK, Airaksinen MSA, Väisänen T, Enlund H. Assessing the importance of community pharmacies as providers of drug information. J Appl Ther Res. 2004;5:24–8.
14.
go back to reference National Agency for medicines and social Insurance Institution. The Finnish Statistics of Medicine 2005. Helsinki: Edita Prima Oy; 2006. ISSN 0786-2180. National Agency for medicines and social Insurance Institution. The Finnish Statistics of Medicine 2005. Helsinki: Edita Prima Oy; 2006. ISSN 0786-2180.
15.
go back to reference Sihvo S, Ahonen R, Mikander H, Hemminki E. Self-medication with vaginal antifungal drugs: physicians’ experiences and women’s utilization patterns. Fam Pract. 2000;17:145–9.CrossRefPubMed Sihvo S, Ahonen R, Mikander H, Hemminki E. Self-medication with vaginal antifungal drugs: physicians’ experiences and women’s utilization patterns. Fam Pract. 2000;17:145–9.CrossRefPubMed
16.
go back to reference Tiihonen MJ, Heikkinen A-M, Ahonen RS. Do Finnish women using hormone replacement therapy need more information about risks. Pharm World Sci. 2007;29:635–40.CrossRefPubMed Tiihonen MJ, Heikkinen A-M, Ahonen RS. Do Finnish women using hormone replacement therapy need more information about risks. Pharm World Sci. 2007;29:635–40.CrossRefPubMed
17.
go back to reference Leppänen H-M. Ehkäisypillereiden käytön edut ja haitat—tutkimus e-pillereiden käyttäjien kokemuksista [The benefits and adverse reactions of oral contraceptive users—users’ experiences]. Master’s thesis (unpublished), Department of Social Pharmacy, University of Kuopio; 2002. Leppänen H-M. Ehkäisypillereiden käytön edut ja haitat—tutkimus e-pillereiden käyttäjien kokemuksista [The benefits and adverse reactions of oral contraceptive users—users’ experiences]. Master’s thesis (unpublished), Department of Social Pharmacy, University of Kuopio; 2002.
18.
go back to reference Sundby J, Svanemyr J, Maehre T. Avoiding unwanted pregnancy—the role of communication, information and knowledge in the use of contraception among young Norwegian women. Patient Educ Couns. 1999;38:11–9.CrossRefPubMed Sundby J, Svanemyr J, Maehre T. Avoiding unwanted pregnancy—the role of communication, information and knowledge in the use of contraception among young Norwegian women. Patient Educ Couns. 1999;38:11–9.CrossRefPubMed
19.
go back to reference Stewart DC, George J, Bond CM, Cunningham IT, Diack HL, McCaig DJ. Exploring patients’ perspectives of pharmacist supplementary prescribing in Scotland. Pharm World Sci. 2008;30:892–7.CrossRefPubMed Stewart DC, George J, Bond CM, Cunningham IT, Diack HL, McCaig DJ. Exploring patients’ perspectives of pharmacist supplementary prescribing in Scotland. Pharm World Sci. 2008;30:892–7.CrossRefPubMed
20.
go back to reference Collaborative Group On Epidemiological Studies of Ovarian Cancer, Beral V, Doll R, Hermon C, Peto R, Reeves G. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet. 2008;371:303–14. Collaborative Group On Epidemiological Studies of Ovarian Cancer, Beral V, Doll R, Hermon C, Peto R, Reeves G. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet. 2008;371:303–14.
21.
go back to reference de Boer MJ, Versteegen GJ, van Wijhe M. Patients’ use of the Internet for pain-related medical information. Patient Educ Couns. 2007;68:86–97.CrossRefPubMed de Boer MJ, Versteegen GJ, van Wijhe M. Patients’ use of the Internet for pain-related medical information. Patient Educ Couns. 2007;68:86–97.CrossRefPubMed
22.
go back to reference Sihvo S, Hemminki E. Self-medication of dyspepsia: how appropriate is it? Scand J Gastroenterol. 1997;32:855–61.CrossRefPubMed Sihvo S, Hemminki E. Self-medication of dyspepsia: how appropriate is it? Scand J Gastroenterol. 1997;32:855–61.CrossRefPubMed
Metadata
Title
Information sources used by women in Finland who use hormonal contraceptives
Authors
Miia Tiihonen
Anna-Mari Heikkinen
Hanna-Mari Leppänen
Riitta Ahonen
Publication date
01-02-2010
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 1/2010
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-009-9344-6

Other articles of this Issue 1/2010

International Journal of Clinical Pharmacy 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.